Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chlorpromazine induces cytotoxic autophagy in glioblastoma cells via endoplasmic reticulum stress and unfolded protein response
Silvia Matteoni, Paola Matarrese, Barbara Ascione, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Unlocking hidden potential: advancements, approaches, and obstacles in repurposing drugs for cancer therapy
Freya R. Weth, Georgia B. Hoggarth, Anya F. Weth, et al.
British Journal of Cancer (2023) Vol. 130, Iss. 5, pp. 703-715
Open Access | Times Cited: 68
Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target
Shuo Qie, Nianli Sang
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 60
Deciphering Glioblastoma: Fundamental and Novel Insights into the Biology and Therapeutic Strategies of Gliomas
Răzvan Onciul, Felix-Mircea Brehar, Corneliu Toader, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 3, pp. 2402-2443
Open Access | Times Cited: 8
Targeting autophagy to enhance chemotherapy and immunotherapy in oral cancer
Xiaoli Zeng, Yue Chen, Jing Wang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Recent advances in glioblastoma multiforme therapy: A focus on autophagy regulation
Mehdi Sanati, Maryam Moradi Binabaj, Seyed Sajad Ahmadi, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113740-113740
Open Access | Times Cited: 25
Repurposing phenothiazines for cancer therapy: compromising membrane integrity in cancer cells
Syrina Mehrabi, S.Abdullahi Elmi, Jesper Nylandsted
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 13
Targeting autophagy by antipsychotic phenothiazines: potential drug repurposing for cancer therapy
Rayssa de Mello Lopes, Ana Carolina Santos de Souza, Michał Otręba, et al.
Biochemical Pharmacology (2024) Vol. 222, pp. 116075-116075
Closed Access | Times Cited: 5
Antipsychotics possess anti-glioblastoma activity by disrupting lysosomal function and inhibiting oncogenic signaling by stabilizing PTEN
John R. Jacob, Kamalakannan Palanichamy, Arnab Chakravarti
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 5
Unraveling the potential of neuroinflammation and autophagy in schizophrenia
Hongxia Tao, Cheng‐Xiang Wang, Chuan Zou, et al.
European Journal of Pharmacology (2025) Vol. 997, pp. 177469-177469
Closed Access
Nanomedicine Approaches for Autophagy Modulation in Cancer Therapy
Sohaib Mahri, Raffaella Villa, Ya‐Ping Shiau, et al.
Small Science (2025)
Open Access
Drug repositioning: Using psychotropic drugs for the treatment of glioma
Fangting You, Caiyi Zhang, Xiaoxiao Liu, et al.
Cancer Letters (2021) Vol. 527, pp. 140-149
Open Access | Times Cited: 27
Methotrimeprazine is a neuroprotective antiviral in JEV infection via adaptive ER stress and autophagy
Surendra Kumar Prajapat, Laxmi Mishra, Sakshi Khera, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 1, pp. 185-217
Open Access | Times Cited: 4
The unfolded protein response machinery in glioblastoma genesis, chemoresistance and as a druggable target
Lucette Simbilyabo, Liting Yang, Jie Wen, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 4
PSMC2 promotes resistance against temozolomide in glioblastoma via suppressing JNK-mediated autophagic cell death
Pritam Roy, K Deepak, Chandan Kanta Das, et al.
Biochemical Pharmacology (2025), pp. 116755-116755
Closed Access
Therapeutic Mechanisms of Phenothiazine Drugs: A Mini-Review of Advances in Cancer Treatment and Antibiotic Resistance
Xiangyu Zou, Bai Xie
Deleted Journal (2025) Vol. 24, Iss. 1
Open Access
Combination of Ascorbic Acid and Menadione Induces Cytotoxic Autophagy in Human Glioblastoma Cells
Ana Despotović, Aleksandar Mirčić, Sonja Misirlić‐Denčić, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-18
Open Access | Times Cited: 17
A Surprising Repurposing of Central Nervous System Drugs against Squamous Cell Carcinoma of the Bladder, UM-UC-5
Maria João Gouveia, Eduarda Ribeiro, Nuno Vale
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 212-212
Open Access | Times Cited: 3
Autophagy machinery in glioblastoma: The prospect of cell death crosstalk and drug resistance with bioinformatics analysis
Yi Qin, Shengjun Xiong, Jun Ren, et al.
Cancer Letters (2023) Vol. 580, pp. 216482-216482
Closed Access | Times Cited: 8
Six Decades of Dopamine Hypothesis: Is Aryl Hydrocarbon Receptor the New D2?
Adonis Sfera
Reports — Medical Cases Images and Videos (2023) Vol. 6, Iss. 3, pp. 36-36
Open Access | Times Cited: 7
Chlorpromazine affects glioblastoma bioenergetics by interfering with pyruvate kinase M2
Claudia Abbruzzese, Silvia Matteoni, Paola Matarrese, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 7
Evidence for cytoprotective autophagy in response to HER2-targeted monoclonal antibodies
Ahmed M. Elshazly, Aya A. Elzahed, David A. Gewirtz
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 392, Iss. 1, pp. 100007-100007
Open Access | Times Cited: 2
The combination therapy using tyrosine kinase receptors inhibitors and repurposed drugs to target patient-derived glioblastoma stem cells
Małgorzata Kucińska, Julia Pospieszna, Jing Tang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116892-116892
Open Access | Times Cited: 2
Chlorpromazine overcomes temozolomide resistance in glioblastoma by inhibiting Cx43 and essential DNA repair pathways
Paola Matarrese, Michele Signore, Barbara Ascione, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma
Michele Persico, Claudia Abbruzzese, Silvia Matteoni, et al.
Cells (2022) Vol. 11, Iss. 2, pp. 263-263
Open Access | Times Cited: 12
The role of phenothiazine derivatives in autophagy regulation: A systematic review
Michał Otręba, Jerzy Stojko, Anna Rzepecka‐Stojko
Journal of Applied Toxicology (2022) Vol. 43, Iss. 4, pp. 474-489
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top